Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
Official title:
A Study Evaluating the Effects of a Structured Lifestyle Intervention on Daily Physical Activity Level of COPD Patients in the First, Second and Third Echelon.
Chronic Obstructive Pulmonary Disease (COPD) is increasing in the Netherlands. COPD is
characterized by a deterioration of lung function, a lowering physical activity level and a
low state of quality of life.
The aim of this randomized controlled study is to investigate the effects of a structured
lifestyle program compared with usual care (in the first, second and third echelon) on the
physical activity level of COPD patients.
150 COPD patients (GOLD I-IV) will be included, aged between 40 and 80 years. In each
echelon 25 patients will participate in a structured lifestyle program and 25 patients will
be treated with usual care.
In the structured lifestyle program, patients will be stimulated individually to enhance a
physically active lifestyle. The primary outcome parameter is daily physical activity
(steps/ day) assessed with a pedometer.
According to the study protocol patients in the experimental group and the control group
participate in four measurement sessions distributed over 15 months. In each assessment a
physical fitness test, lung function and questionnaires are taken. Patients of the
experimental group participate in five individual counseling sessions and one telephonic
counseling.
Background of the study: Chronic Obstructive Pulmonary Disease (COPD) is increasing in the
Netherlands. The incidence of COPD is about 2-3 per 1000 and the prevalence of 12-19 per
1000 patients in the Dutch primary health care. The World Health Organization (WHO) states
that its prevalence in 2020 will be on the fourth rank of death and the fifth rank of causes
of disability-adjusted life years lost worldwide. COPD is characterized by a deterioration
of lung function, a lowering physical activity level and a low state of quality of life.
Objective of the study: The aim of the study is to investigate the effects of a structured
lifestyle program (in the first, second and third echelon) on the physical activity level of
COPD patients
Study design: It concerns a randomized controlled study. In this study a structured
lifestyle program will be compared with usual care in the first, second and third echelon of
the health care.
Study population: 150 COPD patients (GOLD I-IV) will be included, aged between 40 and 80
years. In each echelon 25 patients will participate in a structured lifestyle program and 25
patients will be treated with usual care.
Intervention: A structured lifestyle program, based on the COACH method, will be used. This
method was developed by the Institute of Human Movement Sciences of the University of
Groningen (RUG). Using COACH, patients will be stimulated individually to enhance a
physically active lifestyle.
Primary study parameters/outcome of the study: Daily physical activity (steps/ day)
Secondary study parameters/outcome of the study: Personal characteristics, Body Mass Index,
Fat Free Mass, lung function (FEV1), physical fitness (arm strength, leg strength,
respiratory muscle strength, 6MWT), COPD related costs, ADL activities, type of activity,
attitude towards physical activity, health status, physical fitness, psychological factors
(self-efficacy, depression), quality of life, fatigue.
Nature and extent of the burden and risks associated with participation, benefit and group
relatedness: According to the study protocol patients in the experimental group and the
control group participate in five measurement sessions. In each assessment a physical
fitness test, lung function, questionnaires is taken. Al participants wear a pedometer to
registrate the number of steps a day during 2 weeks after each appointment. Patients of the
experimental group participate in five individual counseling sessions and one telephonic
counseling. As a result of the type of assessments used, the study has a very low risk
profile.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03282019 -
Study of Long-term HFNC for COPD Patients With HOT
|
N/A | |
| Completed |
NCT05573464 -
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
| Recruiting |
NCT06040086 -
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
|
Phase 3 | |
| Not yet recruiting |
NCT06376994 -
Multi-Center Clean Air Randomized Controlled Trial in COPD
|
Phase 3 | |
| Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
| Completed |
NCT02926534 -
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
N/A | |
| Completed |
NCT02728674 -
Management of Patients With Respiratory Symptoms in Sweden
|
N/A | |
| Recruiting |
NCT02415478 -
Bronchioscopic Lung Volume Reduction (BLVR)
|
N/A | |
| Completed |
NCT02512510 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT02774226 -
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
| Completed |
NCT03487406 -
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
|
Phase 2 | |
| Completed |
NCT02459080 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT02518139 -
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01908140 -
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01893476 -
A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
|
N/A | |
| Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
| Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
| Completed |
NCT01701869 -
Microbiology & Immunology of the Chronically-inflamed Airway
|
N/A | |
| Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
| Terminated |
NCT01388920 -
Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting
|
Phase 2 |